Drawing for MELANOMASEQ

USPTO serial 86400633

MELANOMASEQ

Reviewed by CopyMark Law Group

Reg. 4989322Status 702Renewal
Filing date
Status date
Registration date
Jun 28, 2016
Examiner
KON, ELISSA GARBER
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MELANOMASEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen C. Kline

Karen C. Kline DUANE MORRIS LLP5100 Town Center Circle, Suite 400BR-IPDBoca Raton, FL 33486

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research in the field of cancer treatment and diagnosis featuring molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for scientific and clinical research purposesACTIVE—
044Medical testing for diagnostic and treatment purposes in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers; diagnostic testing in the field of molecular analysis, gene sequencing and tumor profiling for individual cancers, for medical diagnostic and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 20, 2026PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Jul 20, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 19, 2026E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 28, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 13, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 13, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 13, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 28, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Jun 28, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 19, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 28, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
May 25, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 24, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 17, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 19, 2016IUAFUSE AMENDMENT FILED—
Apr 19, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 20, 2015NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 25, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2015NPUBNOTICE OF PUBLICATION—
Jul 21, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 21, 2015ALIEASSIGNED TO LIE—
Jul 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 7, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2015CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jan 8, 2015CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jan 5, 2015DOCKASSIGNED TO EXAMINER—
Sep 30, 2014MPMKNOTICE OF PSEUDO MARK MAILED—
Sep 29, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance